Phase II trial of Lestaurtinib, a JAK2 inhibitor, in patients with myelofibrosis

John Mascarenhas, Maria R. Baer, Craig Kessler, Elizabeth Hexner, Douglas Tremblay, Leah Price, Lonette Sandy, Rona Weinberg, Heike Pahl, Lewis R. Silverman, Judith D. Goldberg, Heidi Kosiorek, Amylou C. Dueck, Ronald Hoffman

Research output: Contribution to journalLetterpeer-review

16 Scopus citations
Original languageEnglish
Pages (from-to)1343-1345
Number of pages3
JournalLeukemia and Lymphoma
Issue number5
StatePublished - 16 Apr 2019

Cite this